The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction : Ameliorative Effect of Solifenacin Succinate (Vesicare^【○!R】), a Bladder-Selective Antimuscarinic Agent, on Overactive Bladder Symptoms, Especiall
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-02-20
著者
-
SASAMATA Masao
Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.
-
MIYATA Keiji
Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.
-
Miyata Keiji
Applied Pharmacology Res. Laboratories Drug Discovery Res. Astellas Pharma Inc. Jpn
-
Sasamata Masao
Applied Pharmacology Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Sato Shuichi
Applied Pharmacology Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Ohtake Akiyoshi
Applied Pharmacology Research Laboratories Drug Discovery Research Astellas Pharma Inc.
-
Sasamata Masao
Applied Pharmacology Res. Laboratories Drug Discovery Res. Astellas Pharma Inc.
-
Miyata Keiji
Applied Pharmacology Res. Laboratories Drug Discovery Res. Astellas Pharma Inc.
-
Ohtake Akiyoshi
Applied Pharmacology Res. Laboratories Drug Discovery Res. Astellas Pharma Inc.
関連論文
- New Topics in Vasopressin Receptors and Approach to Novel Drugs : Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia
- Pharmacological Characterization of a New Antimuscarinic Agent, Solifenacin Succinate, in Comparison with Other Antimuscarinic Agents(Pharmacology)
- Effects of Intravenously and Orally Administered Solifenacin Succinate (YM905) on Carbachol-Induced Intravesical Pressure Elevation and Salivary Secretion in Mice(Pharmacology)
- The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Ameliorative Effect of Solifenacin Succinate (Vesicare®), a Bladder-Selective Antimuscarinic Agent, on Overactive Bladder Symptoms, Especially Urge
- Relationship between the Functional Effect of Tamsulosin and Its Concentration in Lower Urinary Tract Tissues in Dogs(Pharmacology)
- Enzymologic and Pharmacologic Profile of Loxoprofen Sodium and Its Metabolites(Pharmacology)
- A Novel Vasopressin Dual V_/V_2 Receptor Antagonist, Conivaptan Hydrochloride, Improves Hyponatremia in Rats with Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)(Pharmacology)
- Inhibitory Effects of Ramosetron, a Potent and Selective 5-HT_3-Receptor Antagonist, on Conditioned Fear Stress-Induced Abnormal Defecation and Normal Defecation in Rats : Comparative Studies With Antidiarrheal and Spasmolytic Agents
- Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats
- Evaluation of the Pharmacological Profile of Ramosetron, a Novel Therapeutic Agent for Irritable Bowel Syndrome
- The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction : Ameliorative Effect of Solifenacin Succinate (Vesicare^【○!R】), a Bladder-Selective Antimuscarinic Agent, on Overactive Bladder Symptoms, Especiall
- Tamsulosin Potently and Selectively Antagonizes Human Recombinant .ALPHA.1A/1D-Adrenoceptors: Slow Dissociation from the .ALPHA.1A-Adrenoceptor May Account for Selectivity for .ALPHA.1A-Adrenoceptor over .ALPHA.1B-Adrenoceptor Subtype
- Tacrolimus Ameliorates Dextran Sulfate Sodium-Induced Colitis in Mice: Implication of Interferon-.GAMMA. and Interleukin-1.BETA. Suppression